These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7887444)

  • 1. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size.
    Zhuang Z; Bertheau P; Emmert-Buck MR; Liotta LA; Gnarra J; Linehan WM; Lubensky IA
    Am J Pathol; 1995 Mar; 146(3):620-5. PubMed ID: 7887444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.
    Zhuang Z; Roth MJ; Emmert-Buck MR; Lubensky IA; Liotta LA; Solomon D
    Acta Cytol; 1994; 38(5):671-5. PubMed ID: 8091895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
    Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-needle aspiration of metastatic clear cell carcinoma of the kidney: employment of microdissection and the polymerase chain reaction as a potential diagnostic tool.
    Beaty MW; Zhuang Z; Park WS; Emmert-Buck MR; Linehan WM; Lubensky IA; Abati A
    Cancer; 1997 Jun; 81(3):180-6. PubMed ID: 9196017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of tissue microdissection in cancer genetics.
    Zhuang Z; Vortmeyer AO
    Cell Vis; 1998; 5(1):43-8. PubMed ID: 9660725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The loss of heterozygosity on the short arm of chromosome 3 in renal carcinoma].
    Maestro de las Casas ML; del Barco Barriuso V; Moreno Sierra J; Izquierdo López L; Sanz Casla MT; Zanna I; Redondo González E; Chicharro Almarza J; Fernández Pérez C; Resel Estévez L
    Arch Esp Urol; 1999; 52(1):3-9. PubMed ID: 10101881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
    Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
    Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
    Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
    J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
    Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
    Shuin T; Kondo K; Torigoe S; Kishida T; Kubota Y; Hosaka M; Nagashima Y; Kitamura H; Latif F; Zbar B
    Cancer Res; 1994 Jun; 54(11):2852-5. PubMed ID: 8187067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
    Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
    Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens.
    Zhuang Z; Emmert-Buck MR; Roth MJ; Gnarra J; Linehan WM; Liotta LA; Lubensky IA
    Hum Pathol; 1996 Feb; 27(2):152-6. PubMed ID: 8617456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the VHL tumour suppressor gene in renal carcinoma.
    Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
    Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.